Carcinoid Syndrome

Common Name(s)

Carcinoid Syndrome

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Carcinoid Syndrome" for support, advocacy or research.

Logo
NET Patient Foundation

The Charity’s objects (“the Objects”) are: 1. to advance the education of the general public (including relevant medical and scientific communities) in all areas relating to NETs. 2. to promote the physical and mental health of those affected by NETs through the provision of support, advice and education to patients, their carers and family members.

Last Updated: 9 Nov 2014

View Details

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Carcinoid Syndrome" for support, advocacy or research.

Logo
NET Patient Foundation

The Charity’s objects (“the Objects”) are: 1. to advance the education of the general public (including relevant medical and scientific communities) in all areas relating to NETs. 2. to promote the physical and mental health of those affected by NETs through the provision of support, advice and education to patients, their carers and family members.

http://www.netpatientfoundation.org

Last Updated: 9 Nov 2014

View Details

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Carcinoid Syndrome" returned 162 free, full-text research articles on human participants. First 3 results:

Understanding the Patient Experience with Carcinoid Syndrome: Exit Interviews from a Randomized, Placebo-controlled Study of Telotristat Ethyl.
 

Author(s): Lowell Anthony, Claire Ervin, Pablo Lapuerta, Matthew H Kulke, Pamela Kunz, Emily Bergsland, Dieter Hörsch, David C Metz, Janice Pasieka, Nick Pavlakis, Marianne Pavel, Martyn Caplin, Kjell Öberg, John Ramage, Emily Evans, Qi Melissa Yang, Shanna Jackson, Karie Arnold, Linda Law, Dana B DiBenedetti

Journal: Clin Ther. 2017 Nov;39(11):2158-2168.

 

Telotristat ethyl, an oral tryptophan hydroxylase inhibitor, is intended to treat carcinoid syndrome by reducing serotonin production. Telotristat ethyl was evaluated in TELESTAR, a Phase III study for patients who had carcinoid syndrome with at least 4 bowel movements (BMs) per day ...

Last Updated: 31 Dec 1969

Go To URL
Carcinoid Syndrome and Carcinoid Heart Disease as Manifestations of Non-Metastatic Ovarian Neuroendocrine Tumour.
 

Author(s): Joana Simões-Pereira, Lai Mun Wang, Attila Kardos, Ashley Grossman

Journal: Acta Med Port. 2017 May;30(5):421-425.

 

The carcinoid syndrome is rare but it is associated with carcinoid heart disease in more than a half of the cases. Carcinoid heart disease is typically characterised by morphological and functional modifications of right-sided valves. Its aetiology is probable multifactorial but serotonin ...

Last Updated: 31 Dec 1969

Go To URL
Cushing's syndrome secondary to typical pulmonary carcinoid with mutation in BCOR gene: A case report.
 

Author(s): Yimin Wu, Lan Yue, Jinfan Li, Mingjing Yuan, Ying Chai

Journal: Medicine (Baltimore). 2017 Aug;96(34):e7870.

 

Typical pulmonary carcinoid is a kind of low-grade malignancy neuroendocrine tumor. Cushing's syndrome is a very rare clinical feature of typical pulmonary carcinoid caused by hypercorticism. Complete tumor resection is the standard curative treatment for primary typical pulmonary ...

Last Updated: 31 Dec 1969

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Carcinoid Syndrome" returned 11 free, full-text review articles on human participants. First 3 results:

Severe psychosis due to Cushing's syndrome in a patient with a carcinoid tumour in the lung: a case report and review of the current management.
 

Author(s): Mohamad Baba, Debamalya Ray

Journal:

 

Severe psychosis in patients with Cushing's syndrome is a rare occurrence and can be extremely resistant to medical therapy. We describe a case of a 51-year-old Afro-Caribbean female patient, with refractory severe hypertension (initially resistant to polypharmacy) and gradual development ...

Last Updated: 31 Dec 1969

Go To URL
In patients with carcinoid syndrome undergoing valve replacement: will a biological valve have acceptable durability?
 

Author(s): Nigel Mabvuure, Alex Cumberworth, Sandip Hindocha

Journal: Interact Cardiovasc Thorac Surg. 2012 Sep;15(3):467-71.

 

A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was 'In patients with carcinoid syndrome undergoing valve replacement, will a biological valve have acceptable durability?' Altogether, more than 130 papers were found using ...

Last Updated: 31 Dec 1969

Go To URL
The endocrine tumor summit 2008: appraising therapeutic approaches for acromegaly and carcinoid syndrome.
 

Author(s): Anne Klibanski, Shlomo Melmed, David R Clemmons, Annamaria Colao, Regina S Cunningham, Mark E Molitch, Aaron I Vinik, Daphne T Adelman, Karen J P Liebert

Journal: Pituitary. 2010 Sep;13(3):266-86.

 

The Endocrine Tumor Summit convened in December 2008 to address 6 statements prepared by panel members that reflect important questions in the treatment of acromegaly and carcinoid syndrome. Data pertinent to each of the statements were identified through review of pertinent literature ...

Last Updated: 31 Dec 1969

Go To URL
 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Real-world Evidence Study EvaLuating PAtient-Reported Outcomes With XERMELO
 

Status: Recruiting

Condition Summary: Carcinoid Syndrome

 

Last Updated: 18 Jul 2017

Go to URL
AMT-PET in Monitoring Telotristat Etiprate Treatment in Participants With Metastatic Well Differentiated Neuroendocrine Neoplasm
 

Status: Not yet recruiting

Condition Summary: Carcinoid Syndrome; Metastatic Nonfunctional Well Differentiated Neuroendocrine Neoplasm

 

Last Updated: 10 Apr 2018

Go to URL
Cabozantinib S-malate in Treating Patients With Neuroendocrine Tumors Previously Treated With Everolimus That Are Locally Advanced, Metastatic, or Cannot Be Removed by Surgery
 

Status: Not yet recruiting

Condition Summary: Atypical Carcinoid Tumor; Carcinoid Tumor; Digestive System Neuroendocrine Neoplasm; Enterochromaffin Cell Serotonin-Producing Pancreatic Neuroendocrine Tumor; Functional Pancreatic Neuroendocrine Tumor; Intermediate Grade Lung Neuroendocrine Neoplasm; Low Grade Lung Neuroendocrine Neoplasm; Lung Atypical Carcinoid Tumor; Lung Carcinoid Tumor; Metastatic Digestive System Neuroendocrine Tumor G1; Neuroendocrine Neoplasm; Nonfunctional Pancreatic Neuroendocrine Tumor; Pancreatic Neuroendocrine Tumor; Stage IIIA Digestive System Neuroendocrine Tumor AJCC v7; Stage IIIB Digestive System Neuroendocrine Tumor AJCC v7; Stage IV Digestive System Neuroendocrine Tumor AJCC v7

 

Last Updated: 12 Mar 2018

Go to URL